Research Paper Volume 15, Issue 18 pp 9809—9821
The oncogenic miR-429 promotes triple-negative breast cancer progression by degrading DLC1
Figure 5. DLC1 expression correlates with the anticancer properties of TNBC. (A) HE and IHC staining of TNBC. Scale bar = 100 μm. (B) Correlation of DLC1 immunostaining intensity with clinical TNM stage and histopathological grade of TNBC, respectively. (C) Kaplan-Meier survival curves for overall survival of 114 patients with TNBC according to the DLC1 expression. Patients were stratified into high-expression and low-expression groups by median expression. (* p < 0.05, ** p < 0.01, and *** p < 0.001).